BCM-95™ Turmeric has been supported by two clinical trials – for rheumatoid and osteoarthritis – and four bioavailability studies.

BCM-95™ Turmeric and BosPure Boswellia, in combination, have been found to significantly reduce pain and joint tenderness in patients with osteoarthritis: A randomised, controlled 12 week trial with BCM-95™ and BosPure in combination found 93% of patients saw an improvement in symptoms, including pain, walking distance and joint tenderness.

Devil’s claw exerts antinociceptive effects and Jamaica dogwood may alleviate pain by supporting local blood flow and inhibiting inflammatory enzymes.

Anti-inflammatory and tissue integrity: BosPure Boswellia exerts an anti-inflammatory action via inhibition of the 5-lipoxygenase enzyme and down regulating TNFa, while also reducing the cartilage degrading enzyme matrix metalloproteinase-3 (MMP-3).

While Devil’s claw inhibits MMP-2 and nitric oxide (NO) to protect against inflammatory joint destruction. BCM-95™ exerts multiple anti-inflammatory actions via inhibition of NF-kB, reducing transcription of inflammatory genes, such as COX-2, and inhibiting pro inflammatory compounds, including IL-6, IL-8 and MMP-3.

Joint Sustained Care offers an evidence-based option for managing joint pain and inflammation, for patients seeking long-term joint health support.

Warnings

If symptoms persist consult your healthcare professional. In very rare cases, Curcuma species may harm the liver. Stop use and see a doctor if you have yellowing skin/eyes or unusual: fatigue, nausea, appetite loss, abdominal pain, dark urine, or itching.

*Before taking this product please consult your healthcare professional to determine suitability, especially if you have pre-existing medical conditions or are taking other medications. If you are pregnant or breastfeeding always consult your healthcare professional before taking any medications.